company
CareFusion 213, LLC
Industry: pharmaceutical
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_recall · drug_recall2026-07-01CareFusion 213, LLC — Class II recall: BD ChloraPrep FREPP Clear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v iso…
- fda_recall · drug_recall2026-07-01CareFusion 213, LLC — Class II recall: BD ChloraPrep Clear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl…
- fda_recall · drug_recall2026-07-01CareFusion 213, LLC — Class I recall: BD ChloraPrep FREPP Clear,(2% w/v chlorhexidine gluconate (CHG) and 70% v/v isop…
- fda_recall · drug_recall2026-07-01CareFusion 213, LLC — Class I recall: BD ChloraPrep Clear (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl…
- fda_recall · drug_recall2026-05-13CareFusion 213, LLC — Class II recall: BD PurPrep, Povidone-iodine 8.3% w/w (0.83% available iodine) with isopropyl alc…
- fda_recall · drug_recall2026-05-13CareFusion 213, LLC — Class II recall: BD PurPrep, Povidone-iodine 8.3% w/w (0.83% available iodine) with isopropyl alc…
- fda_warning_letter · cgmp2026-04-30CareFusion 213, LLC — CGMP/Finished Pharmaceuticals/Adulterated (2026-04-30)
Frequently asked questions
- How many FDA warning letters has CareFusion 213, LLC received?
- Argus HQ has recorded 1 FDA warning letter for CareFusion 213, LLC.
- What FDA recalls has CareFusion 213, LLC issued?
- Argus HQ has recorded 6 FDA recalls tied to CareFusion 213, LLC.
- Is CareFusion 213, LLC FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 1 warning letter, 6 recalls, and 0 approval records for CareFusion 213, LLC. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.